Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-87,243.93
% of Total Estimate Gain
-10.32%

CONTINENTAL INVESTORS SERVICES, INC.'s SPDR Biotech ETF Holding Summary

As of 2025-03-31, CONTINENTAL INVESTORS SERVICES, INC. held - shares of SPDR Biotech ETF(XBI), totaling N/A. This investment constitutes 0% of their stock portfolio, and CONTINENTAL INVESTORS SERVICES, INC. now holds 0% of the outstanding SPDR Biotech ETF(XBI) stock.

The initial trade took place in 2021Q4. And since then CONTINENTAL INVESTORS SERVICES, INC. has made 4 purchases of XBI, at an average price of $90.45, for a total of 9,344.00 shares. In addition, there have been 3 sales at an average price of $81.11 for 9,344.00 shares. Based on historical transaction data and XBI's current price of $86.45, CONTINENTAL INVESTORS SERVICES, INC.'s estimated gain on his XBI holdings is $-87,243.93, reflecting a -10.32% gain to date.

CONTINENTAL INVESTORS SERVICES, INC. XBI ($86.45) Holding Chart

CONTINENTAL INVESTORS SERVICES, INC. XBI ($86.45) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1